MY119896A - Long-acting injection suspensions and a process for their preparation. - Google Patents

Long-acting injection suspensions and a process for their preparation.

Info

Publication number
MY119896A
MY119896A MYPI94003276A MYPI9403276A MY119896A MY 119896 A MY119896 A MY 119896A MY PI94003276 A MYPI94003276 A MY PI94003276A MY PI9403276 A MYPI9403276 A MY PI9403276A MY 119896 A MY119896 A MY 119896A
Authority
MY
Malaysia
Prior art keywords
preparation
long
injection suspensions
acting injection
acting
Prior art date
Application number
MYPI94003276A
Inventor
Professor Dr Jurgen Engel
Karin Dr Klokkers-Bethke
Thomas Dr Reissmann
Peter Dr Hilgard
Original Assignee
Aeterna Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4342092A external-priority patent/DE4342092B4/en
Application filed by Aeterna Zentaris Gmbh filed Critical Aeterna Zentaris Gmbh
Publication of MY119896A publication Critical patent/MY119896A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A61K38/105—Bombesin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

POORLY SOLUBLE SALTS OF LHRH ANALOGUES, FOR EXAMPLE CETRORELIX EMBONATE, DISPLAY AN INTRINSIC SUSTAINED RELEASE EFFECT IN THE GRAIN SIZE 5 UM TO 200 UM.
MYPI94003276A 1993-12-09 1994-12-08 Long-acting injection suspensions and a process for their preparation. MY119896A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4342092A DE4342092B4 (en) 1993-12-09 1993-12-09 Long-acting suspension for injection and method of preparation

Publications (1)

Publication Number Publication Date
MY119896A true MY119896A (en) 2005-08-30

Family

ID=35953452

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI94003276A MY119896A (en) 1993-12-09 1994-12-08 Long-acting injection suspensions and a process for their preparation.

Country Status (6)

Country Link
KR (1) KR100344330B1 (en)
DE (1) DE69434553T2 (en)
MY (1) MY119896A (en)
SI (1) SI0732934T1 (en)
TW (1) TW327176B (en)
UA (1) UA44722C2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4342092A1 (en) * 1993-12-09 1995-06-14 Asta Medica Ag Long-acting suspension for injection and method of manufacture

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4342092A1 (en) * 1993-12-09 1995-06-14 Asta Medica Ag Long-acting suspension for injection and method of manufacture

Also Published As

Publication number Publication date
KR100344330B1 (en) 2002-11-30
SI0732934T1 (en) 2006-02-28
KR960706353A (en) 1996-12-09
DE69434553T2 (en) 2006-08-10
UA44722C2 (en) 2002-03-15
TW327176B (en) 1998-02-21
DE69434553D1 (en) 2005-12-29

Similar Documents

Publication Publication Date Title
HRP940978A2 (en) Long-acting injection suspensions and a process for their preparation
CA2178592A1 (en) Long-acting injection suspensions and a process for their preparation
PL325825A1 (en) Microemulsion for use as a carrier for administering active compounds
EP2016950A8 (en) Pharmaceutical composition comprising an exendin-4 peptide
GR3026338T3 (en) High release solid preparation, preparation and use thereof
GB8922026D0 (en) Novel anti-viral and cytotoxic agent
CA2203033A1 (en) Compounds and compositions for delivering active agents
AU8418891A (en) Novel polyamines and method for preparation thereof
IL106693A (en) Controlled sustained release tablets containing bupropion hydrochloride
CA2354034A1 (en) Compositions containing a peptide and polylactic-glycolic acid suitable for preparing subcutaneous implants with an extended release period
TW370532B (en) The use of cetrorelix and other nona and decapeptides in the preparation of a medicament for combating AIDS and for growth stimulation
CA2135062A1 (en) Pharmaceutical and Other Dosage Forms
AU1179795A (en) Improved immunogenic compositions against human gastrin 17
HU9501767D0 (en) Aqueous pharmaceutical preparations of g-csf with a long shelf life
MY106528A (en) Method of treating impotence.
MX9710206A (en) Pharmaceutical amiodarone composition for parenteral delivery.
AU620218B2 (en) Anti-hiv drug
MY119896A (en) Long-acting injection suspensions and a process for their preparation.
CA2273272A1 (en) Immediate release drug delivery forms
MX9804120A (en) New lh-rh antagonists with improved effectiveness.
MY105110A (en) Low molecular weight derivatives of prourokinase and pharmaceutical compositions containing the same
CA2021282A1 (en) Dispenser comprising ionophore
AU5886390A (en) Pharmaceutically active derivative delivery systems